+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Graves Ophthalmopathy - Pipeline Insight, 2024 - Product Thumbnail Image

Graves Ophthalmopathy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Restrictive Cardiomyopathy - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Restrictive Cardiomyopathy - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • March 2024
  • 123 Pages
  • Global
From
Warm Autoimmune Hemolytic Anemia (WAIHA) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Warm Autoimmune Hemolytic Anemia (WAIHA) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • March 2024
  • 134 Pages
  • Global
From
Giant-Cell Arteritis - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Giant-Cell Arteritis - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • February 2024
  • 156 Pages
  • Global
From
Gastroparesis - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Gastroparesis - Market Insight, Epidemiology and Market Forecast - 2034

  • Drug Pipelines
  • February 2024
  • 144 Pages
  • Global
From
Alport Syndrome - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Alport Syndrome - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • February 2024
  • 126 Pages
  • Global
From
Pulmonary Arterial Hypertension Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Pulmonary Arterial Hypertension Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • January 2024
  • 250 Pages
  • Global
From
Cough in Idiopathic Pulmonary Fibrosis (IPF) - Market Insights, Epidemiology, and Market Forecast - 2034 - Product Thumbnail Image

Cough in Idiopathic Pulmonary Fibrosis (IPF) - Market Insights, Epidemiology, and Market Forecast - 2034

  • Report
  • January 2024
  • 145 Pages
  • Global
From
Sarcopenia Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Sarcopenia Market Insight, Epidemiology and Market Forecast - 2032

  • Drug Pipelines
  • January 2024
  • 136 Pages
  • Global
From
Angiotensin-converting Enzyme (ACE) Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast - 2034 - Product Thumbnail Image

Angiotensin-converting Enzyme (ACE) Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast - 2034

  • Report
  • January 2024
  • 120 Pages
  • Global
From
Dipeptidyl Peptidase IV (DPP-4) Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast - 2034 - Product Thumbnail Image

Dipeptidyl Peptidase IV (DPP-4) Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast - 2034

  • Report
  • January 2024
  • 120 Pages
  • Global
From
Opioid Kappa Receptor Agonists Market Size, Target Population, Competitive Landscape & Market Forecast - 2034 - Product Thumbnail Image

Opioid Kappa Receptor Agonists Market Size, Target Population, Competitive Landscape & Market Forecast - 2034

  • Report
  • January 2024
  • 120 Pages
  • Global
From
Glucagon-like Peptide-1 (GLP-1) Agonists Market Size, Target Population, Competitive Landscape & Market Forecast - 2034 - Product Thumbnail Image

Glucagon-like Peptide-1 (GLP-1) Agonists Market Size, Target Population, Competitive Landscape & Market Forecast - 2034

  • Report
  • January 2024
  • 120 Pages
  • Global
From
Complement Inhibitors (C3/C5) Market Size, Target Population, Competitive Landscape & Market Forecast - 2034 - Product Thumbnail Image

Complement Inhibitors (C3/C5) Market Size, Target Population, Competitive Landscape & Market Forecast - 2034

  • Report
  • January 2024
  • 120 Pages
  • Global
From
Generalized Anxiety Disorder Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Generalized Anxiety Disorder Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • January 2024
  • 160 Pages
  • Global
From
Atypical Hemolytic Uremic Syndrome (aHUS) - Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Atypical Hemolytic Uremic Syndrome (aHUS) - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • January 2024
  • 158 Pages
  • Global
From
Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) - Market Insights, Epidemiology, and Market Forecast - 2032 - Product Thumbnail Image

Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) - Market Insights, Epidemiology, and Market Forecast - 2032

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Japan Non-Alcoholic Steatohepatitis (NASH) - Market Insights, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Japan Non-Alcoholic Steatohepatitis (NASH) - Market Insights, Epidemiology and Market Forecast - 2032

  • Report
  • January 2024
  • 267 Pages
  • Japan
From
Japan Alzheimer's Disease - Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Japan Alzheimer's Disease - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • January 2024
  • 200 Pages
  • Japan
From
Japan Alzheimer's Disease - Epidemiology Forecast - 2032 - Product Thumbnail Image

Japan Alzheimer's Disease - Epidemiology Forecast - 2032

  • Report
  • January 2024
  • 100 Pages
  • Japan
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more